These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35875460)

  • 1. The 27-Item Multiple Sclerosis Quality of Life Questionnaire: A New Brief Measure Including Treatment Burden and Work Life.
    Beckmann H; Heesen C; Augustin M; Blome C
    Int J MS Care; 2022; 24(4):147-153. PubMed ID: 35875460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS).
    Gold SM; Heesen C; Schulz H; Guder U; Mönch A; Gbadamosi J; Buhmann C; Schulz KH
    Mult Scler; 2001 Apr; 7(2):119-30. PubMed ID: 11424632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.
    Beckmann H; Augustin M; Heesen C; Poettgen J; Blome C
    Mult Scler Relat Disord; 2019 Feb; 28():256-261. PubMed ID: 30639826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation and Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS) for Use in Iranian Patients.
    Rezaei S; Saberi A; Hatamian H; Ghayeghran A; Khaksari Z; Mollahosein F
    Acta Neurol Taiwan; 2022 Jan; 31(1)():24-35. PubMed ID: 34988951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of patient-reported outcome measures in multiple sclerosis.
    Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C
    Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
    Martínez-Ginés ML; García-Domínguez JM; Forero L; Canal N; Rebollo P; Prefasi D; Honan CA; Maurino J
    Mult Scler Relat Disord; 2018 May; 22():115-119. PubMed ID: 29656271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial.
    Robinson D; Zhao N; Gathany T; Kim LL; Cella D; Revicki D
    Curr Med Res Opin; 2009 May; 25(5):1121-30. PubMed ID: 19317608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity, responsiveness, and score interpretation of the PROMISnq Physical Function - Multiple Sclerosis 15a short form in multiple sclerosis.
    Kamudoni P; Amtmann D; Johns J; Cook KF; Salem R; Salek S; Raab J; Middleton R; Repovic P; Alschuler KN; von Geldern G; Wundes A; Barrett A; Olayinka-Amao O; Henke C
    Mult Scler Relat Disord; 2022 Jun; 62():103753. PubMed ID: 35598408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of korean versions of the multiple sclerosis impact scale and the multiple sclerosis international quality of life questionnaire.
    Huh SY; Joo J; Kim SH; Joung AR; Park K; Kim W; Park MS; Kim HJ
    J Clin Neurol; 2014 Apr; 10(2):148-56. PubMed ID: 24829601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis.
    van Egmond E; van Gorp D; Honan C; Heerings M; Jongen P; van der Klink J; Reneman M; Beenakker E; Frequin S; de Gans K; Hengstman G; Hoitsma E; Mostert J; Verhagen W; Zemel D; Middelkoop H; Visser L; van der Hiele K
    Disabil Rehabil; 2021 Jun; 43(13):1924-1933. PubMed ID: 31702954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.
    Printza A; Kalaitzi M; Bakirtzis C; Nikolaidis I; Proios H; Grigoriadis N
    Mult Scler Relat Disord; 2018 Jul; 23():62-68. PubMed ID: 29778042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life assessment in patients with multiple sclerosis].
    Tepavcević DK; Pekmezović T; Drulović J
    Vojnosanit Pregl; 2009 Aug; 66(8):645-50. PubMed ID: 19780420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rate.
    Doesburg D; Vennegoor A; Uitdehaag BMJ; van Oosten BW
    Mult Scler Relat Disord; 2019 Jun; 31():32-37. PubMed ID: 30901702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
    Jones E; Pike J; Marshall T; Ye X
    BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire.
    Ghaem H; Borhani Haghighi A; Jafari P; Nikseresht AR
    Neurol India; 2007; 55(4):369-75. PubMed ID: 18040110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity and Reliability of the Greek Version of the Multiple Sclerosis International Quality-of-Life Questionnaire.
    Triantafyllou N; Triantafillou A; Tsivgoulis G
    J Clin Neurol; 2009 Dec; 5(4):173-7. PubMed ID: 20076798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.